Enhanced chemiluminescent immunoassay for aldosterone

Area of Science:

• Endocrinology
• Clinical Chemistry
• Immunochemistry

Background:

• Aldosterone is a key hormone in regulating blood pressure and electrolyte balance.
• Accurate measurement of aldosterone is crucial for diagnosing conditions like Conn's syndrome and Addison's disease.
• Existing immunoassays may have limitations in sensitivity or complexity.

Purpose of the Study:

• To develop and validate a novel solid-phase immunoassay for aldosterone detection.
• To utilize enhanced chemiluminescent (ECL) technology for improved sensitivity and signal duration.
• To compare the performance of monoclonal and polyclonal antibodies in the assay.

Main Methods:

• Development of a solid-phase immunoassay using monoclonal antibodies against aldosterone.
• Comparison with a polyclonal antibody-based assay utilizing different solid phases.
• Enzyme labeling of aldosterone with horseradish peroxidase (HRP).
• Optimization of chemiluminescent reaction conditions using luminol, p-iodophenol, and hydrogen peroxide.

Main Results:

• The developed immunoassay demonstrated high sensitivity with a detection limit of 100 fg/tube.
• The assay provided a prolonged luminescence signal, simplifying measurement procedures.
• Excellent precision was observed with coefficients of variation ranging from 4.2% to 7.3%.
• A strong correlation (r = 0.91) was found between the ECL immunoassay and ELISA.
• Significantly elevated aldosterone levels were detected in patients with Conn's syndrome, while levels were near the detection limit in Addison's disease patients.

Conclusions:

• The enhanced chemiluminescent immunoassay is a sensitive, precise, and efficient method for aldosterone measurement.
• This assay simplifies detection procedures and allows for repeated measurements.
• The assay effectively differentiates aldosterone levels in patients with specific endocrine disorders.